Beep Beep!
I am not sure, but I think we all fell for one of the Road Runner's sneaky tricks on Monday.
The market finished way up on hope that the Parliament of Whores in DC had reached an agreement to keep us from falling off the cliff. The Dow finished the year at 13,104 versus my February prediction of 13,073. The S&P 500 finished at 1,426 versus my peg of 1,358. The deltas were .2% and 5%.
We were not sitting back sucking up eggnog over the break. While we were waiting for a confirmation of a true correction (which was dramatically reversed on Monday with unusual heavy volume to the upside and a VIX which dropped and gold which advanced-yes we have a green flag flying again) we executed a few trades.
In March 2012, the S&A 12% news letter floated the idea of getting into ECA below 25 a share. I have had it on a watch list since March. I liked the two year weekly, 6 month daily, and 1 month 60 minute charts and finally saw a nice entry point. $19.50 looks like a nice base for a two year double.
An excerpt from the March newsletter, "Based in one of the "energy capitals" of the world - Calgary, Alberta - Encana is a big, well-managed, blue-chip natural gas exploration and production company with $8.9 billion in annual sales and over 4,100 employees. It's the second-biggest natural gas producer in North America (after ExxonMobil). In 2010, Encana produced 3.18 billion cubic feet of gas per day. As of the third quarter of 2011, it was producing 3.5 billion cubic feet per day.
Encana's prized asset is its 11.7 million acres of energy-rich land, from northern British Columbia, Canada through the Rocky Mountains to the Gulf Coast of Alabama. With huge landholdings in some of the best shale gas plays in the U.S., Encana is well-positioned to exploit the Bush legacy..."
We are LONG ECA at$19.49 with a stop at $18.75. My target is 40.00 in 24 months. We will write option contracts around this position while we own it.
We sold some February 162 PUT options against GLD, assuming a bump in price from 162 to 168-170 by mid January. We are Long GLD.
We wrote (sold) some February 700 calls on GOOG as the long term, intermediate, and short term charts are all saying a correction to 680 or lower. We are LONG GOOG.
Now in a strange and freaky logic and with Devin's help, we executed a couple of trades based upon the aging baby boomer market. I have had RMD and SYK on watch lists for a long time.
ResMed Inc., through its subsidiaries, engages in the development, manufacture, and distribution of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. It offers various products for the treatment of obstructive sleep apnea and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear products, and ventilation devices, as well as other optional accessories, such as cold passover humidifiers, carry bags, and breathing circuits. The company also provides data communications and data control products consisting of EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. ResMed Inc. markets its products to sleep clinics, home healthcare dealers, and third-party payers. The company sells its products through a network of distributors, independent manufacturers, representatives, and direct sales force in approximately 70 countries primarily in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Japan, Norway, and Sweden. ResMed Inc. was founded in 1989 and is based in San Diego, California.
Stryker Corporation, together with its subsidiaries, operates as a medical technology company. The company operates in three segments: Reconstructive, MedSurg, and Neurotechnology and Spine. The Reconstructive segment offers orthopaedic reconstructive (hip and knee) and trauma implant systems, as well as other related products. The MedSurg segment provides surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling and emergency medical equipment, reprocessed and remanufactured medical devices, and other medical device products. The Neurotechnology and Spine segment includes neurovascular products, spinal implant systems, and other related products. The company sells its products through local dealers and direct sales force to doctors, hospitals, and other healthcare facilities, as well as through third-party dealers and distributors primarily in the United States, Ireland, Germany, France, Switzerland, the United Kingdom, Japan, Canada, the Pacific region, and Latin America. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
While we fell asleep with RMD (pun intended), we feel the stock is temporarily over bought and due for a haircut. This will be a long position for us but we will short it to catch a better price.
We are SHORT RMD at 41.64 looking for an LONG entry below 39.50. We have a protective buy at 42.50.
As far as SYK, we like the 54.25 entry, have a stop at 49.75. We are looking for 66.50 by fall 2013.
We hope you had a great new year and look forward to publishing this, my first post of 2013.
Salve Lucrum |